Laura Díaz Sáez

Laura Díaz Sáez

Auto-generated profile, based on publicly available information

Laura Díaz Sáez

The Blas Cabrera Institute of Physical Chemistry, Madrid, Spain

Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
7 November 2023 in Bioorganic & Medicinal Chemistry Letters
Verified
Journal Article
Closed access
BRBrigitt Raux
Brigitt Raux
KBKarly A. Buchan
Karly A. Buchan
JBJames Bennett
James Bennett
TCThomas Christott
Thomas Christott
MDMatthew S. Dowling
Matthew S. Dowling
ALAllyn T. Londregan
Allyn T. Londregan

10 March 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
JWJonathan R. Whiteside
Jonathan R. Whiteside
NLNick Lewis
Nick Lewis
LDLaura Díaz-Sáez
Laura Díaz-Sáez
HNHector Newman
Hector Newman
SNSarah Newell
Sarah Newell
CRCatherine E. Rowland
Catherine E. Rowland
α-Hemolysin (Ahly) is a major Staphylococcus aureus virulence determinant implicated in tissue injury and immune dysregulation; antibody inhibitors have reached clinical trials but alternatives with improved ease of manufacture and tissue penetration are desirable. Here we demonstrate that phage-derived bicyclic peptides can serve as compact, chemically tractable Ahly neutralisers. Using TATB-scaffolded M13 phage libraries we identified WNP-motif containing bicyclic binders, with a lead hit of Peptide 14 (K D = 1792nM) and progressed the lead by iterative affinity maturation to Peptide 20 (K D = 609 nM) and by incorporation of strategically chosen non-canonical amino acids to yield Peptide 88 (KD = 96 nM). A 2.2 Å co-crystal structure with AhlyH35A locates the binding footprint on the rim domain and explains the critical role of the WNP motif in target engagement. Functional assays show that the Peptide 88 blocks Ahly mediated hemolysis, inhibits Ahly driven ADAM10 activation, and elucidate its inhibitory mechanism of preventing Ahly binding to human A549 epithelial cells. Peptide 88 protects A549 cells from recombinant toxin and attenuates cytotoxicity in S. aureus co-culture experiments, whilst showing no toxicity to A549 cells. Bicyclic peptides thus represent a new and promising anti-virulence modality: small, synthetically accessible molecules that mimic antibody recognition, with therapeutic potential against S. aureus infections.